Abstract
(Cell Stem Cell 29, 386–399.e1–e7; March 3, 2022) In the originally published version of this manuscript, the author Nikolaus D. Obholzer was incorrectly listed as Nikolaus P. Obholzer. Additionally, N.D.O.’s declaration of interests information was inadvertently omitted. To address this, the authors have now corrected the author's name and included N.D.O.’s declaration of interests (“N.D.O. is a shareholder of Kronos Bio”). The authors apologize for the oversight and for any resulting confusion.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 650 |
| Number of pages | 1 |
| Journal | Cell Stem Cell |
| Volume | 29 |
| Issue number | 4 |
| DOIs |
|
| State | Published - Apr 7 2022 |
All Science Journal Classification (ASJC) codes
- Molecular Medicine
- Genetics
- Cell Biology
Fingerprint
Dive into the research topics of 'Erratum: An oncogenic enhancer encodes selective selenium dependency in AML (Cell Stem Cell (2022) 29(3) (386–399.e7), (S1934590922000030), (10.1016/j.stem.2022.01.003))'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver